Frontiers in <i>Staphylococcus aureus</i>
Staphylococcus was first recognized as a human pathogen in 1880 and was named for its grape cluster-like appearance. In 1884, Staphylococcus aureus was identified and named for its vibrant golden color, which was later found to be the result of golden toxin production. Here, experts examine in-depth...
Saved in:
Other Authors: | , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
IntechOpen
2017
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_129752 | ||
005 | 20231201 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20231201s2017 xx |||||o ||| 0|eng d | ||
020 | |a 63039 | ||
020 | |a 9789535129820 | ||
020 | |a 9789535129813 | ||
020 | |a 9789535154730 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.5772/63039 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a PSGD |2 bicssc | |
100 | 1 | |a Enany, Shymaa |4 edt | |
700 | 1 | |a Crotty Alexander, Laura E. |4 edt | |
700 | 1 | |a Enany, Shymaa |4 oth | |
700 | 1 | |a Crotty Alexander, Laura E. |4 oth | |
245 | 1 | 0 | |a Frontiers in <i>Staphylococcus aureus</i> |
260 | |b IntechOpen |c 2017 | ||
300 | |a 1 electronic resource (234 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Staphylococcus was first recognized as a human pathogen in 1880 and was named for its grape cluster-like appearance. In 1884, Staphylococcus aureus was identified and named for its vibrant golden color, which was later found to be the result of golden toxin production. Here, experts examine in-depth patterns of S. aureus colonization and exposures in humans, mammals, and birds that have led to the development of various clinical diseases. The mode of transmission of S. aureus and different methods for its detection in different samples are defined. Conventional antibiotic options to treat this aggressive, multifaceted, and readily adaptable pathogen are becoming limited. Alternative, novel chemotherapeutics to target S. aureus are discussed in the pages within, including herbal medicines, bee products, and modes of delivery. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/3.0/ |2 cc |4 https://creativecommons.org/licenses/by/3.0/ | ||
546 | |a English | ||
650 | 7 | |a Bacteriology (non-medical) |2 bicssc | |
653 | |a mrsa, essential oils, antibiotic resistance, sepsis, pcr, transmission | ||
856 | 4 | 0 | |a www.oapen.org |u https://mts.intechopen.com/storage/books/5471/authors_book/authors_book.pdf |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/129752 |7 0 |z DOAB: description of the publication |